Your browser doesn't support javascript.
loading
[Effects of Epimedium pubescens icariine on proliferation and differentiation of human osteoblasts].
Yin, Xiao-xue; Chen, Zhong-qiang; Dang, Geng-ting; Ma, Qing-jun; Liu, Zhong-jun.
Afiliación
  • Yin XX; Third Hospital of Peking University, Beijing 100083, China. yxx2733_cn@sina.com
Zhongguo Zhong Yao Za Zhi ; 30(4): 289-91, 2005 Feb.
Article en Zh | MEDLINE | ID: mdl-15724410
ABSTRACT

OBJECTIVE:

To study the effects of epimedium pubescens icariine on the proliferation and differentiation of human osteoblasts.

METHOD:

Human osteoblasts were obtained by inducting human marrow mesenchymal stem cells (hMSCs) directionally. MTT was used to observe the proliferation and activity of ALP was assayed to observe the differentiation of the third passage human osteoblasts cultured in vitro. The expression of BMP-2 mRNA was checked by RT-PCR.

RESULT:

Epimedium pubescens icariine at the dose of 20 microg x mL(-1) increased greatly the proliferation and differentiation of human osteoblasts and promoted the expression of BMP-2 mRNA.

CONCLUSION:

Epimedium pubescens icariine enhances significantly the proliferation and differentiation of human osteoblasts, which may be mediated by increasing the expression of BMP-2 mRNA.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Osteoblastos / Flavonoides / Factor de Crecimiento Transformador beta / Proteínas Morfogenéticas Óseas / Epimedium Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2005 Tipo del documento: Article País de afiliación: China
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Osteoblastos / Flavonoides / Factor de Crecimiento Transformador beta / Proteínas Morfogenéticas Óseas / Epimedium Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2005 Tipo del documento: Article País de afiliación: China